PHYSIONEAL 35 GLUCOSA 3.86% w/v / 38.6 mg/ml SOLUTION FOR PERITONEAL DIALYSIS

2. What you need to know before you use PHYSIONEAL 35

Your doctor should supervise the administration of this product if it is your first time using it.

Do not use PHYSIONEAL 35

• if you are allergic to the active substances or to any of the other components of this medicine (listed in section 6).

• if you have any non-correctable surgical problem affecting your abdominal wall or cavity, or an uncorrectable condition that increases the risk of abdominal infections
• if you have documented loss of peritoneal function due to severe peritoneal scarring.

Warnings and precautions

Consult your doctor before starting to use PHYSIONEAL 35.

Be particularly cautious:

• If you have severe problems affecting the integrity of the abdominal wall or cavity. For example, in the case of hernia or chronic infection or inflammatory disease affecting the intestines.
• If you have an aortic graft.
• If you have severe breathing difficulties.
• If you experience abdominal pain, elevated body temperature, or notice that the drainage fluid is cloudy or contains particles. This may be a sign of peritonitis (inflamed peritoneum) or infection. You should contact your medical team urgently. Note the batch number of the peritoneal dialysis solution bags you are using and take it along with the drained fluid bag to the medical team. The medical team will decide whether to interrupt treatment or initiate corrective treatment. For example, if you have an infection, your doctor may perform several tests to determine which antibiotic is most suitable for you. Your doctor may give you a broad-spectrum antibiotic effective against a wide range of different bacteria until they know what infection you have.
• If you have a high level of lactate in your blood. You are at high risk of lactic acidosis if:

• you have profoundly low blood pressure
• you have a blood infection
• you have acute kidney failure
• you have a congenital metabolic disorder
• you are taking metformin (a medication used to treat diabetes)
• you are taking medications to treat HIV, especially those called NRTIs.

• If you have diabetes and use this solution, the dose of your medications used to regulate blood sugar levels (e.g., insulin) should be reviewed regularly. In particular, the dose of your diabetes medications should be adjusted when peritoneal dialysis treatment is initiated or changed.
• If you have a corn allergy that may lead to hypersensitivity reactions, including severe allergic reactions known as anaphylaxis. Stop administration immediately and drain the solution from the peritoneal cavity.
• You, probably in conjunction with your doctor, will keep a record of your fluid balance and body weight. Your doctor will monitor your blood parameters at regular intervals, particularly electrolytes (e.g., bicarbonate, potassium, magnesium, calcium, and phosphate), parathyroid hormone, and lipids.
• If you have high bicarbonate levels in your blood.
• Do not use more solution than prescribed by your doctor. Symptoms of excessive administration include abdominal distension, stomach heaviness, and difficulty breathing.
• Your doctor will regularly check your potassium levels. If they drop too low, you may be given potassium chloride to compensate.
• An inadequate sequence of priming or clamping can produce air perfusion into the peritoneal cavity, which can cause abdominal pain and/or peritonitis.
• If you administer unmixed solution, you should immediately perform drainage (emptying) of the solution and use a new mixed bag.
• Due to a disorder called encapsulating peritoneal sclerosis (EPS), which is a rare and known complication of peritoneal dialysis therapy, you, probably in conjunction with your doctor, should be aware of this possible complication. EPS causes:

• abdominal inflammation (belly)
• thickening of the intestines that may be associated with abdominal pain, abdominal distension, or vomiting. EPS can be fatal.

Children

If you are under 18 years of age, your doctor will carefully evaluate the benefits and risks of using this product.

Using PHYSIONEAL 35 with other medicines

• Tell your doctor if you are using or have recently used other medicines, including those obtained without a prescription.
• If you use other medicines, your doctor may need to increase your dose since peritoneal dialysis treatment increases the elimination of certain medicines.
• Be careful if you use heart medications called cardiac glycosides (e.g., digoxin), you may:

• need potassium and calcium supplements
• develop cardiac arrhythmias.
• Your doctor will closely monitor you during treatment, especially your potassium levels.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor before using this medicine. The use of Physioneal is not recommended during pregnancy or breastfeeding unless your doctor advises you to do so.

Driving and using machines

This treatment can cause weakness, blurred vision, or dizziness. Do not drive or use machines if you are affected.

3. How to use PHYSIONEAL 35

PHYSIONEAL 35 should be administered into your peritoneal cavity. This cavity is located in the abdomen (belly) between the skin and the peritoneum. The peritoneum is the membrane that surrounds the internal organs, such as the intestines or liver.

Do not use intravenously.

Follow the administration instructions of this medicine exactly as indicated by the specialized medical team in peritoneal dialysis. If in doubt, consult them again.

If the bag is damaged, it should be discarded.

Dose and frequency

Your doctor will indicate the appropriate glucose concentration and the number of bags you should use each day.

Use in children and adolescents

If you are under 18 years of age, your doctor will carefully evaluate the prescription of this medicine.

If you interrupt treatment with PHYSIONEAL 35

Do not interrupt peritoneal dialysis without your doctor's consent. Interrupting treatment can have harmful consequences for your life.

Method of administration

Before use,

• Warm the bag to 37 °C. Use the specially designed warming plate for this purpose. Never submerge the bag in water to warm it. Never use a microwave oven to warm the bag.
• You must use an aseptic technique during the entire administration of the solution, as you have been taught.
• Before performing an exchange, make sure to wash your hands and the area where you will perform the exchange.
• Before opening the overbag, check that it is the correct solution, the expiration date, and the quantity (volume). Lift the bag to check for leaks (excess liquid in the overbag). Do not use the bag if you find leaks.
• After removing the overbag, check for signs of leaks in the container by pressing firmly on the bag. Check that the breakable seal that separates the two chambers is not broken. If the seal is broken, discard the bag. Do not use the bag if you detect any leaks.
• Check that the solution is clear. Do not use the bag if the solution is cloudy or contains particles.
• Before starting the exchange, check that all connections are secure.

• Mix the two chambers carefully by breaking the breakable seal between the two chambers. Wait until the upper chamber has completely emptied into the lower chamber. Mix the solution carefully, pressing with both hands on the walls of the lower chamber.
• • Consult your doctor if you have any questions or doubts about this product or its use.
  • Use each bag only once. Discard any unused solution.
  • The solution must be administered within 24 hours after mixing.

After use, check that the drainage fluid is not cloudy.

Compatibility with other medicines

Your doctor may prescribe other injectable medicines to be added directly to the PHYSIONEAL 35 bag. In this case, add the medicine through the medication addition site located in the small chamber, before breaking the breakable seal between the two chambers. Use the product immediately after adding the medicine. Consult your doctor if you are unsure.

If you use more PHYSIONEAL 35 bags in 24 hours than you should

If you are administered an excessive dose of PHYSIONEAL 35, you may experience:

• abdominal distension
• stomach heaviness and/or
• difficulty breathing.

Contact your doctor immediately. They will inform you of what to do.

If you have any other questions about the use of this product, ask your doctor.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

If you experience any of the following situations, contact your doctor or peritoneal dialysis unit immediately:

• Hypertension (blood pressure above normal levels),
• inflammation of the ankles or legs, swollen eyes, difficulty breathing, or chest pain (hypervolemia),
• abdominal pain,
• chills (flu-like symptoms), fever.
• inflamed peritoneum (peritonitis)

These are serious side effects. You may need urgent medical attention.

If you experience any side effect, tell your doctor or peritoneal dialysis unit. This includes any possible side effects not listed in this leaflet.

Common (may affect up to 1 in 10 people):

• Changes in your blood parameters:

• increased calcium levels (hypercalcemia)
• decreased potassium levels (hypokalemia) that may cause muscle weakness, muscle contractions, or cardiac arrhythmias.
• • weakness, fatigue
  • fluid retention (edema)
  • weight gain

Uncommon (may affect up to 1 in 100 people)

• decreased fluid removal during dialysis.
• fainting, dizziness, or headache.
• cloudy solution extracted from the peritoneum, stomach pain.
• peritoneal hemorrhage, pus, swelling, or pain around the catheter exit site, and catheter blockage.
• nausea, loss of appetite, indigestion, flatulence (gas), thirst, and dry mouth.
• abdominal distension or inflammation, shoulder pain, abdominal cavity hernia (bulge in the groin).
• changes in your blood parameters:

• lactic acidosis
• increased carbon dioxide levels
• increased sugar levels (hyperglycemia)
• increased white blood cell count (eosinophilia)
• • difficulty sleeping
  • low blood pressure (hypotension)
  • cough
  • muscle or bone pain
  • facial or throat swelling
  • skin rash

Other side effects related to the peritoneal dialysis procedure:

• infection around the catheter exit site, catheter blockage

Reporting of side effects

If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish System of Pharmacovigilance of Medicines for Human Use https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of PHYSIONEAL 35

• • Keep this medicine out of the sight and reach of children.
  • Store in the original packaging.
  • Formats corresponding to 2.0 l and 2.5 l bags: Do not store at a temperature below 4 °C.
• Formats corresponding to 1.5 l bags: Store between 4°C and 30°C.
• • Do not use this medicine after the expiration date stated on the outer packaging label and on the bag after the abbreviation EXP and the symbol ?. The expiration date is the last day of the month indicated.

Discard PHYSIONEAL 35 as indicated.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of the packaging and any unused medicines. This will help protect the environment.

6. Packaging Contents and Additional Information

This leaflet does not contain all the information about this medicine. If you have any doubts or are unsure about anything, ask your doctor.

Composition of PHYSIONEAL 35

The mixed peritoneal dialysis solution contains the following active ingredients:

The other components are: water for injectable preparations and carbon dioxide.

The composition in mmol/l of the mixed solution is:

Appearance of the Product and Packaging Contents

PHYSIONEAL 35 is a colorless, transparent, and sterile solution for peritoneal dialysis.

PHYSIONEAL 35 is packaged in a double-chamber PVC bag. The two chambers are separated by a permanent seal. You should only administer PHYSIONEAL 35 when the solutions from the two chambers are fully mixed.

Each bag is wrapped in an overbag and supplied in a cardboard box.

Only some packaging sizes may be marketed.

Marketing Authorization Holder

Vantive Health, S.L.

Polígono Industrial Sector 14

C/Pouet de Camilo 2

46394 Ribarroja del Turia (Valencia) Spain

Date of revision of this leaflet: August 2017

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Vantive and Physioneal are registered trademarks of Vantive Health Inc. or its subsidiaries